Goldman Sachs’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $2.46M | Sell |
|
|||||
|
2022
Q3 | $4.73M | Buy |
|
|||||
|
2022
Q2 | $3.9M | Buy |
|
|||||
|
2022
Q1 | $3.67M | Buy |
|
|||||
|
2021
Q4 | $2.94M | Buy |
|
|||||
|
2021
Q3 | $4.56M | Buy |
|
|||||
|
2021
Q2 | $5.6M | Sell |
|
|||||
|
2021
Q1 | $5.44M | Sell |
|
|||||
|
2020
Q4 | $13M | Buy |
|
|||||
|
2020
Q3 | $13.1M | Buy |
|
|||||
|
2020
Q2 | $4.88M | Sell |
|
|||||
|
2020
Q1 | $1.88M | Buy |
|
|||||
|
2019
Q4 | $708K | Buy |
|
|||||
|
2019
Q3 | $166K | Sell |
|
|||||
|
2019
Q2 | $209K | Sell |
|
|||||
|
2019
Q1 | $533K | Sell |
|
|||||
|
2018
Q4 | $301K | Sell |
|
|||||
|
2018
Q3 | $1.13M | Buy |
|
|||||
|
2018
Q2 | $691K | Sell |
|
|||||
|
2018
Q1 | $2.43M | Buy |
|
|||||
|
2017
Q4 | $124K | Buy |
|
|||||
|
2017
Q3 | $10K | Sell |
|
|||||
|
2017
Q2 | $543K | Buy |
|
|||||
|
2017
Q1 | $81K | Buy |
|
|||||
|
2016
Q4 | $60K | Sell |
|
|||||
|
2016
Q3 | $98K | Buy |
|
|||||
|
2016
Q2 | $54K | Buy |
|
|||||
|
2016
Q1 | $43K | Buy |
|
|||||
|
2015
Q4 | $44K | Sell |
|
|||||
|
2015
Q3 | $68K | Sell |
|
|||||
|
2015
Q2 | $308K | Sell |
|
|||||
|
2015
Q1 | $355K | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $102K | Buy |
|